Startup
CureApp
株式会社CureApp
#28 (tie) in the Japan Top 100 Startups
| Founded / HQ | 2014 · Tokyo |
|---|---|
| Equity raised to date | ¥13.4B “累計調達額は134億円” Company-stated cumulative · as of 2022-08 · CureApp via BRIDGE |
| Last round | 2022-08 · Series G · ¥7B 約70億円 |
| Latest public valuation | Not publicly disclosed (we do not estimate) |
| Key investors | Carlyle |
| Unicorn | No |
| Website | cureapp.co.jp |
From Japanese sources
Findings from Japanese-language filings, government records, trade press, interviews and job posts, with our English analysis. Items tagged Japanese-only had no English coverage when we checked quickly. Most insightful first.
| 2026-06-01 | GovernmentJapanese-onlyFY2026 fee revision adds reimbursement for CureApp's hypertension app in online consultations 令和8年度診療報酬改定に伴う「CureApp HT 高血圧治療補助アプリ」に関する変更点について From 1 June 2026, doctors can bill 78 points when the app is used with telemedicine, and adoption requirements were relaxed. Reimbursement rules, not technology, have been the bottleneck for Japanese digital therapeutics, so this directly widens CureApp's prescribing base. Source: CureApp (JP release on MHLW fee revision) |
|---|
Overview
CureApp develops prescription digital therapeutics, apps that doctors prescribe as treatment, starting with smoking cessation and hypertension. It was founded in 2014 by Kota Satake and Shin Suzuki. In August 2022 it raised ¥7B from Carlyle in a Series G, taking cumulative funding to ¥13.4B.
Built from: BRIDGE · Carlyle release
Company timeline
Founded
| Date | 2014-07-31· CureApp |
|---|---|
| Founders | Kota Satake, Shin Suzuki |
Funding
| Date | Round | Amount | Lead / key investors | Source |
|---|---|---|---|---|
| 2015-10-06 | Funding | ¥100M 総額約1億円 | PR TIMES | |
| 2017-02-06 | Funding | ¥380M 総額3.8億円 | PR TIMES | |
| 2018-02-26 | Funding | ¥1.5B 総額約15億円 | PR TIMES | |
| 2019-07-05 | Funding | ¥2.2B 総額22億円 | PR TIMES | |
| 2021-03-12 | Funding | ≈¥2.1B; cumulative ¥6.4B 約21億円 | CureApp release (PR TIMES) | |
| 2022-08-16 | Series G | ¥7B; cumulative ¥13.4B 累計調達額は134億円 | Carlyle | BRIDGE |
Key hires & board
None compiled yet.
Milestones
| 2026-06-01 | ProductLaunches CureApp Blood Pressure app· PR TIMES |
|---|---|
| 2026-06-11 | Recognitionascure smoking-cessation programme chosen by Ikoma City for fifth year· PR TIMES |
| 2026-06-16 | TractionKonica Minolta health insurer case study for ascure Dr.· PR TIMES |
| 2026-10-15 | RecognitionHAUDY alcohol-reduction app wins Good Design Award 2026· PR TIMES |
News
| 2026-10-15 | HAUDY alcohol-reduction app wins Good Design Award 2026 減酒治療補助アプリ「HAUDY（ハウディ）※１」が GOOD DESIGN AWARD 2026を受賞· PR TIMES |
|---|---|
| 2026-09-15 | Hypertension LINE bot "Dapan" adds proactive AI and photo logging 高血圧お役立ちLINE「だぱん」が進化。AIが能動的に声かけ、写真を送るだけで血圧の記録・振り返りが可能に· PR TIMES |
| 2026-08-27 | Survey of 10,000: 80% find sustained salt reduction hard 【高血圧意識 1万人調査】全体の約8割が「減塩の継続は難しい」と回答 自分だけでなく家族の血圧を気にかける実態も明らかに· PR TIMES |
| 2026-08-18 | Blood-pressure LINE stickers released 血圧管理あるあるがLINEスタンプで登場！· PR TIMES |
| 2026-07-02 | Salt-reduction campaign passes 10,000 entries 【みんなで減塩祭りキャンペーン開催報告】応募総数10,000人突破！· PR TIMES |
| 2026-06-16 | Konica Minolta health insurer case study for ascure Dr. 【ascure Dr.高血圧治療】コニカミノルタ健康保険組合の導入事例を公開· PR TIMES |
| 2026-06-12 | First DTx Business Roundtable 2026 with 10 companies 【開催報告：DTx業界に新ムーブメント】DTx社会実装に向け、業界を牽引する10社が初集結「DTx Business Roundtable 2026」を開催· PR TIMES |
| 2026-06-11 | ascure smoking-cessation programme chosen by Ikoma City for fifth year CureApp 完全オンライン禁煙プログラム「ascure卒煙」奈良県生駒市の禁煙事業に5年連続で採択· PR TIMES |
| 2026-06-01 | Changes to CureApp HT under FY2026 fee revision 6月1日から施行 令和8年度診療報酬改定に伴う「CureApp HT 高血圧治療補助アプリ」に関する変更点について· PR TIMES |
| 2026-06-01 | Launches CureApp Blood Pressure app CureApp、高血圧の「管理」と「治療」をシームレスにつなぐアプリ「CureApp 血圧」提供開始· PR TIMES |
| 2026-05-28 | Salt-reduction campaign passes 5,000 entries in two weeks 【キャンペーン 中間報告】開始2週間で応募総数が5,000件突破！「みんなで減塩祭り」前回超の大反響· PR TIMES |
| 2026-05-27 | CEO Satake lectures for Toshin/Yotsuya Otsuka CureApp代表 佐竹、配信講義へ登壇東進・四谷大塚「未来発見講座」· PR TIMES |
| 2026-05-14 | World Hypertension Day salt-reduction campaign アンケートに答えて豪華賞品のチャンス！5月17日世界高血圧デー『みんなで減塩祭り』開催· PR TIMES |
| 2026-05-14 | Survey on diet concerns of hypertension patients 【最新調査※】高血圧患者さんの食の悩みがデータで明らかに”食”に関する意識調査約半数が「減塩の重要性」を認識するも、同時に「難しさ」を感じていた！· PR TIMES |
| 2026-05-12 | Salt-reduction day campaign with Yamaki draws 4,000+ entries 【減塩の日 応援キャンペーン 第2弾開催報告】CureApp・ヤマキの共催キャンペーン応募総数4,000件超の反響からうかがえる生活者の健康意識· PR TIMES |
| 2026-04-28 | Event report on data-health planning with UTokyo's Prof. Furui 【開催レポート】第3期データヘルス計画後半戦、どう進める？～東大・古井特任教授と考える、エビデンスに基づく保健事業のあり方～· PR TIMES |
| 2026-04-23 | CureApp exhibits at SusHi Tech Tokyo 2026 【出展情報】CureApp、アジア最大級のグローバルイノベーションカンファレンス「SusHi Tech Tokyo 2026」に出展· PR TIMES |
| 2026-03-27 | CureApp publishes Impact Report 2025 CureApp、2025年度の事業活動をまとめた「 インパクトレポート2025」を発行· PR TIMES |
| 2022-08-16 | Series G: ¥7B; cumulative ¥13.4B· BRIDGE |
| 2021-03-12 | Funding: ≈¥2.1B; cumulative ¥6.4B· CureApp release (PR TIMES) |
Funding rounds in 2026
No 2026 rounds in our database yet. Earlier funding is summarised above from the cited source.